NCT06676410
Clinical Trial to Evaluate the Efficacy and Safety of Codivir® in Addition to Standard Antiretroviral Treatment for HIV Infection in Antiretroviral-naïve Participants
Phase: Phase 2
Role: Lead Sponsor
Start: Jul 20, 2023
Completion: Dec 31, 2024